It sounds paradoxical, but chimeric antigen receptor (CAR) T cells can be more easy-going and more effective at killing cancer cells. Engineering a lackadaisical but still-deadly CAR T cell requires ...
Chimeric antigen receptor (CAR) T cell immunotherapy aims to redirect a patient’s T cells to recognize and destroy malignant cells. These cells are genetically altered to express CARs that combine an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback